María Belen Arriaga

15PUBLICATIONS
37CO-AUTHORS
Clinical chemistry (incl. diagnostics)Major global burdens of diseaseDisease surveillanceBehavioural epidemiologyPhysical education and development curriculum and pedagogy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 16, 2026
Dolutegravir Reduces Human T-Cell Lymphotropic Virus Type 1 Proviral Load and Improves Neurological Outcomes in a Phase 2 Controlled Trial.

Carlos Brites, Iris Montaño-Castellon, María B Arriaga

|Dec 18, 2025
Dolutegravir use is related to lower HTLV-1 proviral load in people co-infected by HIV-1.

Tatiana Fernandez, María B Arriaga, Rafaela Mayoral

|Sep 03, 2025
Body Mass Index and Incident Tuberculosis in Close Tuberculosis Contacts.

María B Arriaga, Gustavo Amorim, Marina C Figueiredo

|May 31, 2024
Effect of Smoking on Longitudinal Interferon γ Release Assay Results Among Close Contacts of People with Pulmonary Tuberculosis.

María B Arriaga, Gustavo Amorim, Marina C Figueiredo

|May 10, 2023
Effectiveness of the self-regulation educational program in increasing knowledge about COVID-19 in Peruvian soldiers.

Denices Soledad Abarca-Fernández, Jhon Alex Zeladita-Huaman, María Belen Arriaga

Pageof 3